Global Reverse Transcription Polymerase Chain Reaction Kits Market Insights, Forecast to 2028

Reverse transcription polymerase chain reaction (RT-PCR) is a popular in vitro method and has an important application in the medical science and biomaterial industry. DNA: RNA is utilized as a template for reverse transcription. Reverse transcriptase enzyme uses mRNA to produce cDNA, a single stranded DNA. This process is known as reverse transcription. In a further process, the DNA polymerase converts single stranded cDNA into double stranded DNA, which could be used as a template for PCR reaction. Reverse transcription polymerase chain reaction is utilized in a laboratory to study gene expression, in the diagnosis of genetic diseases, and in pharmacotherapy. RT-PCR is primarily used to measure mRNA level and the surface proteins and is feasible in the clinical laboratories. RT-PCR is used in detecting the mRNAs, pre-mRNAs, non-coding RNA, and other types of RNA. RT-PCR requires buffer, thermocyclers, nucleotides, template, and enzyme for constructing RT-PCR products. RT-PCR is used as a diagnostic tool for severe acute respiratory syndrome, including Coronavirus indication. RT-PCR test is a rapid and reliable diagnostic assay for detecting coronavirus disease.
Market Analysis and Insights: Global Reverse Transcription Polymerase Chain Reaction Kits Market
Due to the COVID-19 pandemic, the global Reverse Transcription Polymerase Chain Reaction Kits market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Quantitative Reverse Transcription Polymerase Chain Reaction Kits accounting for % of the Reverse Transcription Polymerase Chain Reaction Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Reverse Transcription Polymerase Chain Reaction Kits market size is valued at US$ million in 2021, while the US and Europe Reverse Transcription Polymerase Chain Reaction Kits are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Reverse Transcription Polymerase Chain Reaction Kits landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Reverse Transcription Polymerase Chain Reaction Kits include Roche, Merck(Sigma-Aldrich), Thermo Fisher Scientific, Qiagen N.V., Meridian Bioscience, Takara Bio Inc, Agilent Technologies, Abbott Laboratories and Altona Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Reverse Transcription Polymerase Chain Reaction Kits Scope and Segment
Reverse Transcription Polymerase Chain Reaction Kits market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Reverse Transcription Polymerase Chain Reaction Kits market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Quantitative Reverse Transcription Polymerase Chain Reaction Kits
Digital Reverse Transcription Polymerase Chain Reaction Kits
Segment by Application
Hospitals
Diagnostic Centers
Research Laboratories & Academic Institutes
Pharmaceutical & Biotechnology Companies
Others
By Company
Roche
Merck(Sigma-Aldrich)
Thermo Fisher Scientific
Qiagen N.V.
Meridian Bioscience
Takara Bio Inc
Agilent Technologies
Abbott Laboratories
Altona Diagnostics
Bio-Rad Laboratories
Promega Corporation
Enzo Life Sciences, Inc
Cole-Parmer
Bioneer Corporation
Mylab Discovery Solutions
Biomérieux S.A
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Frequently Asked Questions